You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21

Article info

Article menu

Download PDFPDF

XML
Research Article
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21

Authors

  • Louise M. E. Müller Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Matthew Holmes Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Joanne L. Michael Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Gina B. Scott Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Emma J. West Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Karen J. Scott Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Christopher Parrish Department of HaematologySt. James’s University Hospital Leeds UK PubMed articlesGoogle scholar articles
  • Kathryn Hall Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Sina Stäble Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Victoria A. Jennings Translational Immunotherapy TeamThe Institute of Cancer Research and Royal Marsden Hospital/Institute of Cancer Research NIHR Biomedical Research Centre London UK PubMed articlesGoogle scholar articles
  • Matthew Cullen Haematological Malignancy Diagnostics ServiceSt. James’s University Hospital Leeds UK PubMed articlesGoogle scholar articles
  • Stewart McConnell Department of HaematologySt. James’s University Hospital Leeds UK PubMed articlesGoogle scholar articles
  • Catherine Langton Department of HaematologySt. James’s University Hospital Leeds UK PubMed articlesGoogle scholar articles
  • Emma L. Tidswell Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Darren Shafren School of Biomedical Science and PharmacyUniversity of Newcastle Newcastle Australia PubMed articlesGoogle scholar articles
  • Adel Samson Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Kevin J. Harrington Translational Immunotherapy TeamThe Institute of Cancer Research and Royal Marsden Hospital/Institute of Cancer Research NIHR Biomedical Research Centre London UK PubMed articlesGoogle scholar articles
  • Hardev Pandha Surrey Cancer Research Institute, Leggett Building, Faculty of Health and Medical SciencesUniversity of Surrey Guildford UK PubMed articlesGoogle scholar articles
  • Christy Ralph Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  • Richard J. Kelly Department of HaematologySt. James’s University Hospital Leeds UK PubMed articlesGoogle scholar articles
  • Gordon Cook Section of Experimental Haematology, LIMRUniversity of Leeds, St. James’s University Hospital Leeds UK PubMed articlesGoogle scholar articles
  • Alan A. Melcher Translational Immunotherapy TeamThe Institute of Cancer Research and Royal Marsden Hospital/Institute of Cancer Research NIHR Biomedical Research Centre London UK PubMed articlesGoogle scholar articles
  • Fiona Errington-Mais Section of Infection and Immunity, Leeds Institute of Medical Research (LIMR)University of Leeds, St. James’s University Hospital Level 5, Wellcome Trust Brenner Building (WTBB) LS9 7TF Leeds UK PubMed articlesGoogle scholar articles
  1. ↵a medlmul{at}leeds.ac.uk
  2. ↵b holmes.matthew22{at}yahoo.com
  3. ↵c jonanne_hopper{at}hotmail.co.uk
  4. ↵d g.b.scott{at}leeds.ac.uk
  5. ↵e e.j.west{at}leeds.ac.uk
  6. ↵f k.j.scott{at}leeds.ac.uk
  7. ↵g christopherparrish{at}nhs.net
  8. ↵h kat83df{at}googlemail.com
  9. ↵i s.staeble{at}dkfz-heidelberg.de
  10. ↵j vicki.jennings{at}icr.ac.uk
  11. ↵k matthewcullen{at}nhs.net
  12. ↵l stewart.mcconnnell{at}nhs.net
  13. ↵m Catherine.Langton{at}leedsth.nhs.uk
  14. ↵n e.l.tidswell{at}leeds.ac.uk
  15. ↵o Darren.Shafren{at}newcastle.edu.au
  16. ↵p a.samson{at}leeds.ac.uk
  17. ↵q Kevin.Harrington{at}icr.ac.uk
  18. ↵r H.Pandha{at}surrey.ac.uk
  19. ↵s christy.ralph{at}nhs.net
  20. ↵t richardkelly{at}nhs.net
  21. ↵u gordoncook{at}nhs.net
  22. ↵v alan.melcher{at}icr.ac.uk
  23. ↵w f.errington{at}leeds.ac.uk
View Full Text

Citation

Müller LME, Holmes M, Michael JL, et al
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
Journal for ImmunoTherapy of Cancer 2019;7:164. doi: 10.1186/s40425-019-0632-y

Publication history

  • Received February 13, 2019
  • Accepted June 6, 2019
  • First published July 1, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.